ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
PCRX Company Profile and Key Details
Pacira BioSciences, Inc.
Price Chart
Stock Price Today
Pacira BioSciences, Inc. (PCRX) stock declined over -0.37%, trading at $26.90 on NASDAQ, down from the previous close of $27.00. The stock opened at $26.79, fluctuating between $26.40 and $26.95 in the recent session.
Relevant Articles
SEC Fillings
Current Report (8-k)
Annual Report (10-k)
Stock Price History Chart
Contact Details
About Company
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Company Information
| Employees | 788 |
| Beta | 0.71 |
| Sales or Revenue | $674.98M |
| 5Y Sales Change% | 0.771% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Chief Technical Officer
Mr. Max Reinhardt
Pres of Rest of World
Susan Mesco
Head of Investor Relations
Dr. Roy Winston M.D.
Chief Medical Officer & Orthopedic Franchise
Ms. Kristen Williams J.D.
Chief Admin. Officer & Sec.
Mr. Charles A. Reinhart III, C.P.A., M.B.A.
Chief Financial Officer
Dr. Jonathan Slonin M.D.
Chief Clinical Officer
Mr. Daryl Gaugler
Chief Operating Officer
Mr. David M. Stack
Chairman & Chief Executive Officer
Mr. Dennis McLoughlin
Chief Customer Officer
Mr. Richard Kahr
Vice President of HR
Mr. Charles A. Reinhart III, CPA, M.B.A.
Chief Financial Officer
Ms. Lauren Bullaro Riker
Principal Accounting Officer & Vice President of Fin.
Mr. Robert J. Weiland
Senior Vice President of Alliance Management
Mr. Anthony Molloy III, Esq.
Chief Legal & Compliance Officer
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep